Chemours (CC) Operating Expenses (2014 - 2026)

Chemours' Operating Expenses history runs 13 years deep, the most recent figure standing at $186.0 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 1.64% year-over-year to $186.0 million in Q1 2026; TTM through Mar 2026 was $969.0 million, a 15.77% increase from a year earlier, with the FY2025 full-year figure at $966.0 million, up 17.38% from the prior year.
• Operating Expenses improved to $186.0 million in Q1 2026 per CC's latest filing, from $161.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $806.0 million in Q2 2023 and bottomed at $152.0 million in Q3 2025.
• The 5-year median for Operating Expenses is $186.0 million (2026), against an average of $256.9 million.
• Across the five-year window, Operating Expenses jumped 187.86% in 2023 and slumped 77.3% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $211.0 million in 2022, then increased by 21.8% to $257.0 million in 2023, then fell by 20.62% to $204.0 million in 2024, then declined by 21.08% to $161.0 million in 2025, then advanced by 15.53% to $186.0 million in 2026.
• Per Business Quant, the three latest CC Operating Expenses figures stand at $186.0 million (Q1 2026), $161.0 million (Q4 2025), and $152.0 million (Q3 2025).